劲方医药科技（上海）股份有限公司（股票代码：02595，股票名称：劲方医药-B）于2026年8月5日发布截至2026年7月31日的证券变动月报表，披露了报告期内股本变动及相关信息。
公司普通股H股在香港联交所上市，面值为每股人民币0.1元。报告显示，7月末H股已发行股数由上月底的338,029,020股增加至351,629,020股，增发13,600,000股，相应法定/注册股本从人民币33,802,902元增加至人民币35,162,902元；未上市普通股数量为32,337,610股，法定/注册股本为人民币3,233,761元，均与上月保持一致。截至本月末，已发股本总额为人民币38,396,663元。
根据月报，本月新增H股主要来自于2026年7月17日完成的一次配售发行，共计13,600,000股，发行价格为每股港币34.69元。公司表示，前述变动不影响其公众持股量继续满足香港联交所的最低公众持股要求。报告期内无股份期权或股权激励计划的授予、行使或失效变动，也无购回或注销股份活动。
本次公告由联席公司秘书张巍签署。公司强调将持续遵守香港联交所《上市规则》及相关法律法规的要求，确保发行人信息披露的真实、准确和完整。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.